Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Binliang Zhang"'
Autor:
Lide Yu, Qinqin Wang, Caolin Wang, Binliang Zhang, Zunhua Yang, Yuanying Fang, Wufu Zhu, Pengwu Zheng
Publikováno v:
Molecules, Vol 24, Iss 19, p 3422 (2019)
Three series of novel thienopyrimidine derivatives 9a−l, 15a−l, and 18a−h were designed and synthesized, and their IC50 values against four cancer cell lines HepG-2, A549, PC-3, and MCF-7 were evaluated. Most compounds show moderate cytotoxicit
Externí odkaz:
https://doaj.org/article/cd9a5b279d8547d7ba87fbbd38d36a8e
Publikováno v:
Molecules, Vol 23, Iss 7, p 1553 (2018)
Five series of novel phenylsulfonylurea derivatives, 19a–d, 20a–d, 21a–d, 22a–d and 23a–d, bearing 4-phenylaminoquinoline scaffold were designed, synthesized and their IC50 values against four cancer cell lines (HepG-2, A549, PC-3 and MCF-7
Externí odkaz:
https://doaj.org/article/48ccffc2960e4f138645d10ba69703bf
Publikováno v:
Molecules, Vol 22, Iss 11, p 1870 (2017)
Phosphatidylinositol 3-kinase/Protein kinase B/Mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway is abnormally active in the growth and proliferation of cancer cells. The inhibition of PI3K kinase can effectively block the conduction of
Externí odkaz:
https://doaj.org/article/d30b93edcbd84a159faede28d9dc245d
Autor:
Xin Sun, Binliang Zhang, Leixuan Luo, Yang Yang, Bin He, Qian Zhang, Linxiao Wang, Shan Xu, Pengwu Zheng, Wufu Zhu
Publikováno v:
Bioorganic chemistry. 129
Blocking the PI3K/AKT/mTOR pathway has been widely recognized as an attractive cancer therapeutic strategy because of its crucial role in cell growth and survival. In this study, a novel series of 2-arylurea-1,3,5-triazine derivatives had been synthe
Publikováno v:
RSC chemical biology. 3(10)
Nucleic acids have been extensively modified in different moieties to expand the scope of genetic materials in the past few decades. While the development of unnatural base pairs (UBPs) has expanded the genetic information capacity of nucleic acids,
Autor:
Xin Sun, Zunhua Yang, Qian Zhang, Xiaobo Liu, Pengwu Zheng, Binliang Zhang, Wufu Zhu, Shan Xu, Hehua Xiong
Publikováno v:
New Journal of Chemistry. 44:9053-9063
Two series of [1,2,4]triazolo[4,3-a]pyrazine derivatives bearing 4-oxo-pyridazinone moieties (compounds 21a–l and 22a–l) were designed and their IC50 values were evaluated against three cancer cell lines (A549, MCF-7 and HeLa) and c-Met kinase. A
Autor:
Xin Sun, Binliang Zhang, Leixuan Luo, Yang Yang, Bin He, Qian Zhang, Linxiao Wang, Shan Xu, Pengwu Zheng, Wufu Zhu
Publikováno v:
Bioorganic Chemistry. 131:106336
Autor:
Wufu Zhu, Qinqin Wang, Zunhua Yang, Shan Xu, Lai Luogen, Qi Yang, Zixin Luo, Binliang Zhang, Zhen Xiao
Publikováno v:
RSC Advances. 9:29579-29589
A series of thienopyrimidines containing a pyrazoline unit (4a–d, 7a–d and 13a–l) were designed and synthesized. The target compounds were evaluated for antiproliferative activity against A549, HepG2 and MCF-7 cancer cell lines. Among the twent
Autor:
Ting Xie, Wufu Zhu, Shan Xu, Binliang Zhang, Qi Gu, Pengwu Zheng, Ziqin Liu, Zhen Xiao, Xin Sun, Qian Zhang, Zunhua Yang, Qingqing Jin
Publikováno v:
Bioorganic chemistry. 95
The phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) have been regarded as promising targets for the treatment of cancer. Herein, we synthesized a new series of substituted 2-(thiophen-2-yl)-1,3,5-triazine derivatives as nove
Autor:
Wufu Zhu, Lide Yu, Yuanying Fang, Zunhua Yang, Caolin Wang, Pengwu Zheng, Binliang Zhang, Qinqin Wang
Publikováno v:
Molecules, Vol 24, Iss 19, p 3422 (2019)
Molecules
Volume 24
Issue 19
Molecules
Volume 24
Issue 19
Three series of novel thienopyrimidine derivatives 9a&ndash
l, 15a&ndash
l, and 18a&ndash
h were designed and synthesized, and their IC50 values against four cancer cell lines HepG-2, A549, PC-3, and MCF-7 were evaluated. Most compound
l, 15a&ndash
l, and 18a&ndash
h were designed and synthesized, and their IC50 values against four cancer cell lines HepG-2, A549, PC-3, and MCF-7 were evaluated. Most compound